Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
about
Towards stem cell based therapies for Parkinson's disease.Creating a graft-friendly environment for stem cells in diseased brains.Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in in Vitro Models of Parkinson's Disease via Up-regulation of the Wnt/β-Catenin Pathway.Neurodegenerative disease: Towards transplant therapy.Open Science Meets Stem Cells: A New Drug Discovery Approach for Neurodegenerative Disorders.Modeling Neuropsychiatric and Neurodegenerative Diseases With Induced Pluripotent Stem Cells.Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.Recent Advances: Decoding Alzheimer's Disease With Stem Cells.Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment.Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease modelOleanolic acid enhances neural stem cell migration, proliferation, and differentiation in vitro by inhibiting GSK3β activityEmerging Treatment Approaches for Parkinson's DiseaseModeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem CellsThe Healing Effect of Human Milk Fat Globule-EGF Factor 8 Protein (MFG-E8) in A Rat Model of Parkinson's DiseaseDifferentiation of Glial Cells From hiPSCs: Potential Applications in Neurological Diseases and Cell Replacement Therapy
P2860
Q47877645-D200AB6E-7D41-4354-AB9E-6B8E003BEA40Q47922704-54A7E3E6-7954-43C8-B3EE-725C47ED750AQ49408164-6B5BF7D5-34FB-4F46-888B-E921D97D2E74Q50033915-2D558833-F758-41FE-BC7C-E3A867C694BAQ50105039-B97CCE6A-9417-4424-8E34-8D4BFB6B4A43Q52431644-F79895E2-AB93-4256-85F9-791B35A398ABQ52589683-4AE9BD65-915A-4D3F-817C-DC1FB7EAD31EQ52603658-A1DB0272-69BD-4DED-90A9-CB0C9BDA7B10Q55048859-B7304423-7FE0-41ED-B869-C9482AE4EA12Q55314338-A2DCA630-6F0C-4C07-A863-4912DF037845Q55396058-4C98FEAF-06D4-4776-A3E9-E8C0E5A0CD8DQ57116138-981CE2A4-5EA9-412E-AEA8-7F39B262B229Q57814742-58BBA6A2-26C0-4670-BB0C-E815BEEAD9E8Q57817579-CF521557-7AF8-4910-9CD5-349B451384C9Q58726898-9EA0B4FA-609E-4365-A014-FD5AEE3A00F2Q58779250-090AC064-8D3F-400B-887C-B4F3AE99F975Q58795408-73F8F16C-73DA-40F5-A8A8-9F726A26F971
P2860
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Human iPS cell-derived dopamin ...... ate Parkinson's disease model.
@en
Human iPS cell-derived dopamin ...... ate Parkinson's disease model.
@nl
type
label
Human iPS cell-derived dopamin ...... ate Parkinson's disease model.
@en
Human iPS cell-derived dopamin ...... ate Parkinson's disease model.
@nl
prefLabel
Human iPS cell-derived dopamin ...... ate Parkinson's disease model.
@en
Human iPS cell-derived dopamin ...... ate Parkinson's disease model.
@nl
P2093
P2860
P50
P356
P1433
P1476
Human iPS cell-derived dopamin ...... mate Parkinson's disease model
@en
P2093
Daisuke Doi
Haruhisa Inoue
Hiroaki Magotani
Hiroshi Mizuma
Hirotaka Onoe
Jun Takahashi
Masato Nakagawa
Michio Yamamoto
Ryosuke Takahashi
Satoshi Morita
P2860
P2888
P304
P356
10.1038/NATURE23664
P407
P577
2017-08-01T00:00:00Z
P6179
1091378938